| Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
| ATM |
ataxia telangiectasia mutated |
Mapped by CNV; Mapped by significant region |
IDA[15790808]
|
| SREBF1 |
sterol regulatory element binding transcription factor 1 |
Mapped by significant region |
|
| POU2F3 |
POU class 2 homeobox 3 |
Mapped by significant region |
|
| MYO7A |
myosin VIIA |
Mapped by significant region |
RCA[8622919]
|
| SCAND3 |
SCAN domain containing 3 |
Mapped by LD-proxy |
|
| TCF21 |
transcription factor 21 |
Mapped by CNV; Mapped by significant region |
|
| TAL2 |
T-cell acute lymphocytic leukemia 2 |
Mapped by significant region |
|
| WWOX |
WW domain containing oxidoreductase |
Mapped by significant region |
TAS[10786676]
|
| TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
Mapped by CNV |
IDA[12072434]
|
| TBX1 |
T-box 1 |
Mapped by CNV |
TAS[17273972]
|
| EBF1 |
early B-cell factor 1 |
Mapped by significant region |
|
| ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
NAS[12000754]
|
| NPAS2 |
neuronal PAS domain protein 2 |
Mapped by CNV |
|
| SLC4A11 |
solute carrier family 4, sodium borate transporter, member 11 |
Mapped by CNV |
|
| HEY2 |
hairy/enhancer-of-split related with YRPW motif 2 |
Mapped by significant region |
|
| PRDX5 |
peroxiredoxin 5 |
Mapped by significant region |
IDA[15046979]
|
| OLIG3 |
oligodendrocyte transcription factor 3 |
Mapped by significant region |
|
| GPR139 |
G protein-coupled receptor 139 |
Mapped by significant region |
|
| NLGN1 |
neuroligin 1 |
Mapped by CNV |
|
| PRKRIR |
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
Mapped by significant region |
|
| SPEF2 |
sperm flagellar 2 |
Mapped by significant region |
|